Algo version: 0.98b
SMS Lifesciences India is listed at the NSE Exchange
SMS Lifesciences India [SMSLIFE.NS]
NSE Sector: Healthcare Industry:Biotechnology

Is SMS Lifesciences India stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, SMS Lifesciences India pays dividends. Last time was Wednesday 30th of October 2024 where the investors holding the stock on Monday 23rd of September 2024 were paid INR1.5 per share. Over the last 5 times between 2019 and 2024, SMS Lifesciences India has paid INR7.5 with an average of INR1.5 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for SMS Lifesciences India 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR394.70, you would have made a profit of INR1 271.65 per share or 322.18%

Yes, the average daily trading liquidity for SMS Lifesciences India is INR7 891 thousand. You should therefore be able to get in and out of your positions relatively fast.

SMS Lifesciences India has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.29, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 2.97%, which is challenging.

We have calculated the inflation risk for SMS Lifesciences India to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.